ZyVersa Therapeutics to Participate in a Fireside Chat at
CEO Stephen C. Glover to discuss key updates on the development status of ZyVersa’s Phase 2a-ready Cholesterol Efflux
Globe Newswire1-03-2023, 21:29
Aberdeen International Announces Appointment of Martin 18-02-2023, 06:06